Announced recently at AllAfrica.com, Nigeria has opened their first clinical trial center at Lagos State University College of Medicine, Lasucom. The center was donated by GlaxoSmithKline.
Professor Clement Adebamowo, Chairman, National Health Research Ethics Committee of Nigeria (NHREC) had this to say about the new center:
"We lost our direction because we started to pay more attention to things that are not based on science and to things that are not based on reasoning. Research is a systematic investigation designed to make generalisable knowledge. We need to put in place a programme that guarantees, in a transparent manner, that any research done in Nigeria is credible. We need to invite a lot of research into the country. Research generates employment, new drugs and new discovery. There are many diseases we wish we can find cure for... Research yields exceedingly profitable results."
Search This Blog
Blog Archive
-
▼
2008
(97)
-
▼
November
(15)
- Clinical Trials Market Expected to Grow in India D...
- Parexel Completes Chinese Bridging Study
- CROs Under Fire
- CRO BioReliance Enters Tech-Development
- India's clinical trials not affected by the recession
- MarketWatch: Quintiles, SAS Announce Development o...
- Biotrial, Full-Service CRO and European Leader in ...
- Economic Crisis Presents an Opportunity for the In...
- Mayo Clinic Pulls Out of Clinical Services
- MarketWatch: EyeGate Pharma Enrolls First Dry Eye ...
- Outsourced Clinical Trials Going Through a Rough P...
- Kendle sees revenue increase
- Nurse dismissed for error in clinical trials
- Nigeria Opens Clinical Trial Center
- India, China, Latin America and CEE as Clinical Tr...
-
▼
November
(15)
Without research, there will be no development in any sector. Research is the bedrock of modern science and medicine.
ReplyDeleteOpening a clinical trial center for the country is a highly welcomed development.
Countries like India have generated huge sums of revenue through clinical trials. This has been made possible by the country through creating enabling environment for developed countries to outsource clinical trials to India. The need therefore to train and retrain clinical trial professionals that will handle this emerging increase in clinical trial for the Nigerian market is highly prescribed